Abstract
To the Editor: The potential impact of pharmaceutical industry promotional efforts on physician behavior has received growing attention both in the medical community and among the general public (1, 2). Recent research suggests that interactions between physicians and pharmaceutical companies affect physician requests to add medications to hospital formularies as well as prescribing behavior (3, 4). One specific concern is the influence pharmaceutical company spending may have on resident physicians (5). Meetings between residents and pharmaceutical industry representatives are frequent and commonly take place in the form of company-sponsored conference lunches: over 88% of internal medical residency program directors report that their programs have pharmaceutical company sponsorship of educational conferences (6). These trends have compelled academic hospitals like Massachusetts General Hospital to limit access of pharmaceutical representatives to their physicians (7). Because of these growing concerns in residency training, we looked at the association between pharmaceutical company sponsorship of conferences and patterns of antidepressant prescriptions at the adult outpatient clinic of our psychiatry residency program. We first identified 25 medications that are used as antidepressants in the United States and the corresponding pharmaceutical company that manufactures each one. Patterns of use of these 25 antidepressants were then obtainedPreview Only. This article cannot be rented because we do not currently have permission from the publisher.
Preview Only
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy